Human Drugs View

Product Information
Registration Number DR-XY48310
Generic Name Pegaspargase
Brand Name Oncaspar
Dosage Strength 750 U/mL
Dosage Form Powder for Solution for Injection/ Infusion (IV/IM)
Classification Prescription Drug (RX)
Pharmacologic Category Antineoplastic
Packaging Type I clear glass vial with gray chlorobutyl rubber stopper with aluminum seal and yellow flip-off cap
Manufacturer Lyophilization Services of New England Inc.
Country of Origin United States of America
Trader Les Laboratoires Servier
Importer Servier Philippines, Inc.
Distributor Zuellig Pharma Corporation
Application Type Monitored Release
Issuance Date 23 August 2022
Expiry Date 23 August 2027